Back

Utility of CA-125 in evaluating congestion at hospital admission in patients with acute heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 5 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Attila Frigy

George Emil Palade University of Medicine and Pharmacy, Targu Mures (Romania)

5 More presentations in this session

Presentation thumbnail
A gamified behavioral science intervention to enhance trial enrollment: an embedded study within the FINEARTS-HF trial
Doctor A. Bhatt (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
Deep learning framework for heart failure diagnosis
Doctor W. Chanprasertpinyo (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Clinical profile of heart failure patients starting vericiguat in clinical practice
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the Rockwood Clinical Frailty Scale in patients with acute decompensation of heart failure
Mr A. Maggi (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Echographic predictive factors of worsening outcome in type 1 cardiorenal syndrome
Doctor S. Antit (Tunis, TN)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The role of CA125 as a congestion biomarker in ischemic heart failure
thumbnail
Congress Presentation
Usefulness of CA125 and NT-proBNP for assessing congestion in chronic heart failure. Insights from CARDIOREN registry.
thumbnail
Congress Presentation
CA125 assessment using ABEI-based assay in heart failure: implications for disease severity and cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources